NSE ZYDUSWELL · BSE 531335 · Food Processing · NIFTY 500
Zydus Wellness Share Price
₹522.00
▲ +₹3.06 · 0.59%
Day range · 25 Sep
₹514.40Low₹522.70High
52-week range
₹357.55Low · 2 Mar 2026₹610.95High · 20 Jul 2026
Zydus Wellness Overview
Where the price stands, how it has moved and how it sits against its averages.
Zydus Wellness shares last traded at ₹522.00 on the NSE, up 0.59% on the day. That is 14.6% below the 52-week high of ₹610.95 and 46.0% above the 52-week low of ₹357.55. The stock trades at 88.25× earnings, above the sector average of 21.07. Its market value is ₹16,608 Cr.
Price returns
1 Day▲ +0.59%
1 Week0.00%
This month▼ −1.93%
3 Months▲ +0.40%
6 Months▲ +13.58%
This year▲ +14.42%
1 Year▲ +7.09%
Against the market: 1 Month ▲ +1.62% · 3 Months ▲ +5.20% · 6 Months ▲ +16.20% · This year ▲ +32.52% · 1 Year ▲ +18.93%
Shading grows with the size of the move. We ask our data provider for a newer price every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next check from Mon 26 Oct, 9:15 AM. Its quotes are not real-time — the time at the top shows how current the price is.
Moving averages — price is above 1 of 6
- 20-day average₹538.46 ▼ price 3.1% below
- 50-day average₹538.24 ▼ price 3.0% below
- 10-day average₹534.49 ▼ price 2.3% below
- 100-day average₹532.57 ▼ price 2.0% below
- 5-day average₹524.55 ▼ price 0.5% below
- Today's price₹522.00
- 300-day average₹483.47 ▲ price 8.0% above
Each average is the mean closing price over that many trading days; averages above the current price sit higher on the ladder.
Zydus Wellness Financial Results
Revenue and net profit in ₹ crore, with the full statements underneath.
3,961
347
197
Year by year
| Fiscal year | Revenue | Growth | Net profit | Net margin | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2026 | ₹3,961 Cr | ▲ +46.2% | ₹197 Cr | 5.0% | ₹6.20 | ₹1.20 |
| FY 2025 | ₹2,709 Cr | ▲ +16.4% | ₹347 Cr | 12.8% | ₹10.90 | ₹1.20 |
| FY 2024 | ₹2,328 Cr | ▲ +3.2% | ₹267 Cr | 11.5% | ₹8.39 | ₹1.00 |
| FY 2023 | ₹2,255 Cr | ▲ +12.2% | ₹310 Cr | 13.8% | ₹9.76 | ₹1.00 |
| FY 2022 | ₹2,009 Cr | ▲ +7.6% | ₹309 Cr | 15.4% | ₹9.71 | ₹1.00 |
| FY 2021 | ₹1,867 Cr | ▲ +5.7% | ₹119 Cr | 6.4% | ₹3.91 | ₹1.00 |
| FY 2020 | ₹1,767 Cr | — | ₹142 Cr | 8.0% | ₹4.92 | ₹5.00 |
1,485
1,437
172
−53
119
Quarter by quarter
| Quarter | Revenue | vs prev. qtr | Net profit | Net margin | EPS |
|---|---|---|---|---|---|
| Q1 FY27 | ₹1,437 Cr | ▼ −3.2% | ₹119 Cr | 8.3% | ₹3.74 |
| Q4 FY26 | ₹1,485 Cr | ▲ +53.9% | ₹162 Cr | 10.9% | ₹5.04 |
| Q3 FY26 | ₹965 Cr | ▲ +48.3% | −₹40 Cr | −4.1% | −₹1.25 |
| Q2 FY26 | ₹651 Cr | ▼ −24.4% | −₹53 Cr | −8.1% | −₹1.66 |
| Q1 FY26 | ₹861 Cr | ▼ −5.7% | ₹128 Cr | 14.9% | ₹4.02 |
| Q4 FY25 | ₹913 Cr | ▲ +97.7% | ₹172 Cr | 18.8% | ₹5.37 |
| Q3 FY25 | ₹462 Cr | ▼ −6.3% | ₹6 Cr | 1.4% | ₹0.20 |
| Q2 FY25 | ₹493 Cr | — | ₹21 Cr | 4.2% | ₹0.66 |
Balance sheet — FY26
Owes (liabilities)Shareholders' equity
43%
57%
- Total assets₹10,308 Cr
- Total liabilities₹4,482 Cr
- Shareholders' equity₹5,826 Cr
- Total debt₹3,203 Cr
- Cash & investments₹115 Cr
- Current ratio1.88×
- Revenue growth, 5 yr16.24% a year
- EPS growth, 5 yr9.66% a year
- Operating margin (TTM)7.83%
- Net margin (TTM)4.15%
Cash flow — FY26
Operating activities
▲ ₹254 Cr
Investing activities
▼ −₹2,910 Cr
Financing activities
▲ ₹2,698 Cr
Free cash flow
▲ ₹152 Cr
Net change in cash
▲ ₹44 Cr
Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.
Full financial statements, FY20–FY26
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total revenue | 1,766.82 | 1,866.67 | 2,009.10 | 2,254.79 | 2,327.80 | 2,708.90 | 3,961.00 |
| Cost of revenue | 809.74 | 876.19 | 1,017.94 | 1,196.23 | 1,138.50 | 1,323.40 | 1,613.20 |
| Gross profit | 957.08 | 990.48 | 991.16 | 1,058.56 | 1,189.30 | 1,385.50 | 2,347.80 |
| Operating expenses | 1,516.33 | 1,679.60 | 1,687.09 | 1,952.34 | 2,061.20 | 2,357.20 | 3,646.10 |
| Operating income | 250.49 | 187.07 | 322.01 | 302.45 | 266.60 | 351.70 | 314.90 |
| Depreciation | 26.39 | 25.16 | 23.62 | 25.02 | 23.80 | 28.40 | 146.70 |
| Profit before tax | 121.27 | 112.21 | 306.02 | 290.86 | 260.10 | 358.80 | 230.50 |
| Tax | −20.45 | −6.52 | −2.85 | −19.51 | −6.80 | 11.90 | 33.30 |
| Net profit | 141.72 | 118.73 | 308.87 | 310.37 | 266.90 | 346.90 | 197.20 |
| EPS (₹) | 4.92 | 3.91 | 9.71 | 9.76 | 8.39 | 10.90 | 6.20 |
| Dividend per share (₹) | 5.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.20 | 1.20 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total assets | 5,589.68 | 5,666.43 | 5,692.18 | 5,833.05 | 6,148.40 | 6,441.90 | 10,307.80 |
| Current assets | 775.79 | 846.89 | 813.70 | 907.82 | 1,214.30 | 1,104.20 | 1,366.70 |
| Cash & short-term investments | 192.03 | 252.11 | 196.27 | 107.67 | 316.00 | 109.20 | 114.90 |
| Inventory | 306.18 | 374.36 | 366.88 | 464.73 | 476.00 | 524.70 | 777.00 |
| Property, plant & equipment | 208.20 | 203.31 | 256.39 | 283.32 | 256.40 | 305.50 | 338.40 |
| Total liabilities | 2,129.02 | 1,098.64 | 848.15 | 710.40 | 790.90 | 770.30 | 4,481.80 |
| Current liabilities | 615.16 | 770.92 | 766.81 | 692.40 | 769.40 | 745.50 | 728.50 |
| Total debt | 1,519.83 | 550.40 | 387.34 | 297.21 | 328.70 | 188.30 | 3,202.80 |
| Total equity | 3,460.66 | 4,567.79 | 4,844.03 | 5,122.65 | 5,357.50 | 5,671.60 | 5,826.00 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| From operations | 259.25 | 286.73 | 236.85 | 91.71 | 246.40 | 396.60 | 253.50 |
| From investing | −17.12 | −10.41 | −58.93 | −84.84 | −19.30 | −223.60 | −2,909.90 |
| From financing | −259.69 | −216.43 | −233.82 | −138.49 | −25.70 | −186.30 | 2,698.40 |
| Capital expenditure | −24.63 | −19.66 | −75.44 | −44.96 | −28.50 | −66.30 | −101.70 |
| Dividends paid | −57.58 | −0.19 | −31.88 | −31.89 | −31.90 | −31.80 | −38.20 |
| Net change in cash | −17.56 | 59.89 | −55.90 | −131.62 | 201.40 | −13.30 | 43.90 |
Zydus Wellness vs Peers
Side by side with other food processing companies. The small bars compare each column.
| Company | Price | Change | Market cap | P/E | P/B | ROE (5 yr) | Net margin | Div. yield |
|---|---|---|---|---|---|---|---|---|
| Zydus Wellness This stock | ₹522.00 | ▲ +0.59% | ₹16,608 Cr | 88.25 | 2.85 | 5.46% | 4.15% | 0.23% |
| Nestle India | ₹1,364.90 | ▲ +0.87% | ₹2,63,196 Cr | 80.40 | 53.37 | — | 15.11% | 0.84% |
| Britannia Industries | ₹4,939.00 | ▲ +0.18% | ₹1,18,965 Cr | 51.47 | 25.53 | 57.16% | 13.25% | 1.67% |
| Godrej Industries | ₹1,098.55 | ▲ +0.04% | ₹36,958 Cr | 34.92 | 4.02 | 9.17% | 10.85% | — |
| Tata Consumer Products | ₹983.00 | ▼ −0.28% | ₹97,287 Cr | 67.40 | 4.94 | 7.14% | 8.07% | 0.92% |
| Patanjali Foods | ₹403.85 | ▼ −0.39% | ₹43,943 Cr | 18.91 | 2.81 | 12.07% | 4.50% | 1.14% |
Peer prices and ratios as last reported by the data provider. Company names link to their own pages.
Zydus Wellness Key Metrics
Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.
Zydus WellnessBenchmarkRule-of-thumb bands
Valuation The price against earnings, book value and sales
P/E (TTM)Price ÷ yearly earnings per share
88.25
▲ 319% above the sector average of 21.07
P/E, 12-month rangeLow 30.92 · high 97.99
85%
Today's P/E sits 85% of the way from its low to its high
P/BPrice ÷ book value per share
2.85
P/SMarket cap ÷ last 12 months' revenue
3.66
P/CFPrice ÷ cash flow per share
43.41
Profitability Of every ₹100 of sales, how much is kept?
Gross marginKept after the cost of goods
63.14%
▲ above its 5-yr average of 52.58%
Operating marginKept after running costs
7.83%
▼ below its 5-yr average of 11.75%
Pre-tax marginKept before tax
5.45%
▼ below its 5-yr average of 10.91%
Net marginKept as profit
4.15%
▼ below its 5-yr average of 10.78%
Returns & efficiency How well does it use its money?
Return on equityProfit on shareholders' money
3.43%
▼ below its 5-yr average of 5.46%
Return on assetsProfit on everything it owns
2.35%
▼ below its 5-yr average of 4.46%
Return on investmentProfit on long-term capital
2.58%
▼ below its 5-yr average of 5.04%
Return on capital employedProfit before interest and tax on equity + debt
4.20%
Growth Is the business getting bigger?
Revenue — last 12 months
+66.3%
▲ growing (off the scale)
Revenue — 3 yr, a year
+20.7%
▲ growing
Revenue — 5 yr, a year
+16.2%
▲ growing
Net profit — 3 yr, a year
−14.0%
▼ shrinking
Net profit — 5 yr, a year
+10.7%
▲ growing
EPS — last 12 months
−42.7%
▼ shrinking (off the scale)
EPS — 3 yr, a year
−14.0%
▼ shrinking
EPS — 5 yr, a year
+9.7%
▲ growing
Dividend — 3 yr, a year
+6.3%
▲ growing
Book value — 5 yr, a year
+5.0%
▲ growing
Financial strength Can it pay its bills and debts?
Debt to equityBorrowings for every ₹1 of shareholders' money
0.55×
Current ratioShort-term assets for every ₹1 due within a year
1.88×
Quick ratioLike the current ratio, without inventory
0.81×
Interest coverOperating profit ÷ interest to pay
4.32×
Payout ratioShare of profit paid as dividend
19.35%
Per share What each share stands for
EPS (TTM)
₹5.87
Book value
₹183.09
Cash flow
₹11.95
Dividend
₹1.20
Revenue
₹142.18
The share price is 2.85× the book value behind each share.
Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.
All 109 metrics from the data provider
Valuation
P/E excluding extraordinary items, most recent fiscal year83.92
Current Dividend Yield - Common Stock Primary Issue, LTM0.23
Price to Book - most recent fiscal year2.84
P/E Basic excluding extraordinary items - TTM97.99
P/E including extraordinary items - TTM88.58
P/E excluding extraordinary items low, trailing 12 months30.92
Dividend Yield - 5 Year Average0.32
Price to sales - most recent fiscal year4.18
Dividend Yield - indicated annual dividend divided by closing price0.23
Price to Cash Flow per share - trailing 12 month43.41
Price to Free Cash Flow per Share - most recent fiscal year145.68
P/E Normalized, most recent fiscal year71.27
P/E excluding extraordinary items high, trailing 12 months97.99
P/E excluding extraordinary items, most recent fiscal year quarter88.58
Price to sales - trailing 12 month3.65
Net Debt, LFY30,879.00
Per share
Dividend Per Share - 5 year average1.08
Cash Flow per share - trailing 12 month11.95
Cash Flow per share - most recent fiscal year10.81
EPS including extraordinary items - trailing 12 month5.87
EPS including extraordinary items - most recent fiscal year6.20
EBITD per share - trailing 12 month18.46
Revenue/share - trailing 12 month142.18
EPS excluding extraordinary items - trailing 12 month5.87
EPS Basic excluding extraordinary items - most recent fiscal year6.20
EPS Basic excluding extraordinary items - trailing 12 month5.87
Book value per share - most recent fiscal year183.12
Dividend per share - most recent fiscal year1.20
Revenue/share - most recent fiscal year124.50
EPS Normalized - most recent fiscal year7.30
Book value (tangible) per share - most recent fiscal year−77.15
Dividends per share - trailing 12 month1.20
EPS excluding extraordinary items - most recent fiscal year6.20
Cash per share - most recent fiscal year3.61
Margins
Operating margin - trailing 12 month7.83
Gross Margin - 5 year average52.58
Operating margin - 1st historical fiscal year7.95
Operating Margin - 5 year average11.75
Net Profit Margin % - 1st historical fiscal year4.98
Gross Margin - 1st historical fiscal year59.27
Net Profit Margin % - trailing 12 month4.15
Net Profit Margin - 5 year average10.78
Pretax Margin - 5 year average10.91
Pretax margin - 1st historical fiscal year5.82
Pretax margin - trailing 12 month5.45
Free Operating Cash Flow/Revenue, 5 Year Average5.60
Gross Margin - trailing 12 month63.14
Growth
EPS Change %, TTM over TTM−42.69
Revenue growth rate, 5 year16.24
EPS growth rate, 5 year9.66
Revenue Change % - most recent quarter 1 year ago66.92
Growth rate% - dividend, 3 year6.27
Growth rate% - EPS, 3 year−14.03
Revenue/share (5 yr growth)15.16
Free Operating Cash Flow, 5 Year CAGR−15.70
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR10.20
Capital Spending growth rate, 5 year38.91
Revenue Change %, TTM over TTM66.27
Growth rate% - Revenue, 3 year20.66
Book value per share growth rate, 5 year4.99
EPS Change % - most recent quarter 1 year ago−6.97
Net Profit Margin growth rate, 5 year−4.78
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR7.85
Total Debt, 5 Year CAGR42.22
Financial strength
Net Interest coverage - most recent fiscal year4.32
Free Cash Flow - most recent fiscal year1,136.00
LT debt/equity - most recent fiscal year0.52
Quick ratio - most recent fiscal year0.81
Payout ratio - trailing 12 month20.29
Current ratio - most recent fiscal year1.88
Current EV/Free Cash Flow, LFY96.26
Total debt/total equity - most recent fiscal year0.55
Net Interest coverage - trailing 12 month3.44
Payout ratio - most recent fiscal year19.36
Returns & efficiency
Return on average equity - 5 year average5.46
Net Income/employee - trailing 12 month11,16,914.00
Revenue/employee - most recent fiscal year2,70,19,100.00
Return on investment - most recent fiscal year2.58
Return on average assets - most recent fiscal year2.35
Receivables turnover - most recent fiscal year10.55
Inventory turnover - most recent fiscal year2.48
Revenue/employee - trailing 12 month2,69,26,410.00
Return on average assets - 5 year average4.46
Net Income/employee - most recent fiscal year13,45,157.00
Asset turnover - most recent fiscal year0.47
Return on average equity - most recent fiscal year3.43
Return on investment - 5 year average5.04
Price & volume
Market Cap16,608.33
52 week Low Date2 Mar 2026
Price - 1 Day % Change−2.04
Relative (S&P500) price percent change - 13 week5.20
Avg trading volume last 10 days0.24
Price - 13 week price percent change0.40
Price - 52 week price percent change7.09
Avg Trading Volume Last 3 months16.19
Price - 5 Day % Change−4.76
Price % Change Month To Date−1.93
Relative (S&P500) price percent change - 04 week1.62
52 week High Date20 Jul 2026
Price - 26 week price percent change13.58
PDATE24 Sep 2026
Price - YTD price percent change14.42
Relative (S&P500) price percent change - 52 week18.93
NPRICE520.15
Relative (S&P500) price percent change - 26 week16.20
52 week Low367.55
52 week High611.85
Beta0.50
Relative (S&P500) price percent change - Year to Date32.52
Dividends & Corporate Events
Payouts to shareholders, splits and bonus issues, and company meetings — newest first.
₹5.00
₹1.20
- Dividend yield0.23%
- Payout ratio19.35%
- 5-year average dividend₹1.08 a share
- Latest dividend₹1.20 per share · 17 Jul 2026
Corporate calendar
- MeetingAnnual General Meeting
- BoardQuarterly Results
- Dividend₹1.20 per share · 60% · Final dividend
- BoardAudited Results & Final Dividend
- BoardQuarterly Results
- BoardQuarterly Results
- SplitStock split — face value ₹10 → ₹2
- MeetingAnnual General Meeting
Show 13 older events
- BoardQuarterly Results
- Dividend₹6.00 per share · 60% · Final dividend
- BoardAudited Results, Dividend & Stock Split
- BoardQuarterly Results
- BoardQuarterly Results
- MeetingAnnual General Meeting
- Dividend₹5.00 per share · 50% · Final dividend
- MeetingAnnual General Meeting
- Dividend₹5.00 per share · 50% · Final dividend
- MeetingAnnual General Meeting
- Dividend₹5.00 per share · 50% · Final dividend
- MeetingAnnual General Meeting
- Dividend₹5.00 per share · 50% · Final dividend
About Zydus Wellness
Food Processing
Zydus Wellness Limited operates as an integrated consumer company. It is engaged in development, production, marketing and distribution of health and wellness products. Its portfolio spans category- food and nutrition brands: RiteBite Max Protein, Complan, Sugar Free, Sugar Free D’Lite, I’m Lite, Glucon-D and Nutralite; dietary supplement brands, including WeightWorld and MaxMedix; pet care brand Animigo; and skincare brands like Everyuth and Nycil. Glucon-D is a glucose powder brand. Glucon-D is available in regular flavors of Tangy Orange & Nimbu Pani. Complan is a nutritional drink designed for growing school children and contains 34 vital nutrients along with 100% milk protein to support growth. Nycil is a prickly heat and cooling powder brand. It offers skin care products under the brand name of Everyuth Naturals. It has four manufacturing facilities across three locations - Aligarh, Ahmedabad and Sikkim. It has 18 co-manufacturing facilities in India, UAE, and New Zealand.
Key people
- Tarun AroraChief Executive Officer, Whole Time Director
- Umesh Vinodray ParikhChief Financial Officer
- Nandish Pradip JoshiCompany Secretary, Compliance Officer
Company facts
- NSE symbolZYDUSWELL
- BSE code531335
- ISININE768C01028
- IndustryFood Processing
- IndexNIFTY 500
- Market cap₹16,608 Cr
- Revenue (FY26)₹3,961 Cr
- Net profit (FY26)₹197 Cr
In the News
Recent headlines about Zydus Wellness — they open on Mint in a new tab.
- Volume shocker stocks today: Why Innovassynth, RIR Power, Pashupati Cotspin, Zydus Wellness are soaring - Details here
Volume shocker stocks today: Stocks such as Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness surged in morning deals on Monday, 7 September, amid a spurt in volume.
7 Sep 2026 · 2 min read · Mint ↗ - Milk-based drinks emerge as a new growth frontier
Consumer goods companies are giving milk-based drinks a protein boost as health-conscious consumers shift towards on-the-go products.
14 Aug 2026 · 4 min read · Mint ↗
Stock data comes from the exchange feed via our data provider. It is not real-time and can be delayed, so check the price with your broker before you trade. This page is for information and education only. It is not investment advice, research or a recommendation to buy, sell or hold any security. Investments in the securities market are subject to market risks; read all related documents carefully before investing. See all stocks →
Frequently Asked Questions
Zydus Wellness (NSE: ZYDUSWELL) last traded at ₹522.00 on the NSE, up 0.59% (₹3.06) on the day, as of 25 Sep 2026, 9:57 AM IST. On the BSE it was ₹522.70. The day's range was ₹514.40 – ₹522.70.
Zydus Wellness's 52-week high is ₹610.95 (20 Jul 2026) and its 52-week low is ₹357.55 (2 Mar 2026). At ₹522.00 the share is 14.6% below its high and 46.0% above its low.
Zydus Wellness's market capitalisation is ₹16,608 Cr (₹16,608 Cr). It is part of the NIFTY 500 index.
Zydus Wellness's P/E ratio (trailing 12 months) is 88.25. The sector average is 21.07, so investors pay 319% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹5.87.
Zydus Wellness shares are up 7.09% over the last year, up 14.42% so far this year, up 13.58% over 6 months, up 0.40% over 3 months. Over the last year the stock did 18.93% better than the market.
In FY26 (year to Mar 2026), Zydus Wellness reported revenue of ₹3,961 Cr (up 46.22% on the year before) and a net profit of ₹197 Cr. Earnings per share were ₹6.20.
Yes. Zydus Wellness's latest dividend is ₹1.20 per share (60%, final dividend), with an ex-date of 17 Jul 2026. The dividend yield is 0.23%. It has paid 6 dividends in the records shown on this page.
As of Jun 2026: Promoter 69.64%, FII 3.32%, MF 18.73%, Other 8.31%. Promoter holding rose by 0.01 percentage points from Mar 2026.
Zydus Wellness's listed peers in Food Processing include Nestle India, Britannia Industries, Godrej Industries, Tata Consumer Products, Patanjali Foods. By market capitalisation it ranks #6 of 6 in this group.
No. Zydus Wellness has debt — its debt-to-equity ratio is 0.55 and total debt was ₹3,203 Cr in FY26. Its operating profit covers interest 4.32 times.